Clinical severity prediction in children with osteogenesis imperfecta caused by COL1A1/2 defects

Lin Yang1, Bo Liu2,3, Xinran Dong2

  • 1Department of Pediatric Endocrinology and Inherited Metabolic Diseases, Children's Hospital of Fudan University, 399 Wan Yuan Road, Shanghai, 201102, China.

Insights

A new model predicts Osteogenesis Imperfecta (OI) clinical severity using COL1A1/2 gene variant features. This tool aids in prognosis and management of this genetic bone disorder.

Area of Science:

  • Genetics
  • Molecular Biology
  • Medical Diagnostics

Background:

  • Osteogenesis Imperfecta (OI) is a genetic disorder affecting collagen production, with 90% of cases linked to COL1A1/COL1A2 gene variants.
  • The Sillence classification categorizes OI into four types, each with distinct clinical presentations from mild to lethal.

Purpose of the Study:

  • To develop a clinical severity prediction model for Osteogenesis Imperfecta (OI).
  • To leverage variant features within COL1A1/2 genes for accurate OI prognosis and management.

Main Methods:

  • A random forest model was trained using 790 records from the Human Gene Mutation Database.
  • The model utilized variant-type features and optimized features for COL1A1 and COL1A2 gene defects.

Main Results:

  • The prediction model achieved an AUC of 0.902 for mild/moderate OI using optimized COL1A1 features and 0.731 for COL1A2 defects.
  • Clinical validation on 17 patients showed prediction accuracies of 76.5% for COL1A1 and 88.2% for COL1A2 defects.

Conclusions:

  • An Osteogenesis Imperfecta severity prediction model was successfully established using COL1A1/2 gene variant features.
  • The model demonstrates a prediction accuracy of 76-88%, offering a valuable tool for clinical practice.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.1K
Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.9K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
6.1K